Rapid Screening Tests Struggling to Keep up with Rising Demand

With CV-19 tests under big demand, investors have made a fortune.  (Source 1)

Since March 2020:

  • Laboratory Corporation of America ran from about $100 to about $180
  • Abbott Laboratories jumped from about $62.50 to about $102
  • Co-Diagnostics popped from about $6 to a high of about $32

However, with the virus showing no signs of slowing, the world needs many more tests.

And until a vaccine is deemed safe and effective, we can only hope to manage its spread with the help of COVID-19 tests in hospitals, homes, sports events, airports, schools.

In addition, while the Trump Administration hopes to have 20 million rapid and point-of-care tests available by the end of September 2020, reports Politico, some health experts say the U.S. needs as make as 25 million tests by October just to ensure safe operation of schools, businesses, states, and health facilities.

“States, which have spent months scrambling for protective equipment and testing supplies on the open market, are now competing for the rapid tests.”